How to stabilize the level of ionized calcium and citrate during plateletpheresis.
OBJECTIVE
Citrate reactions are uncomfortable and potentially dangerous to apheresis donors. Reduction of citrate increases comfort, but may lead to platelet clumping.


METHODS
We describe a protocol for stepwise reduction of the volume of ACD-A injected during plateletpheresis. This protocol has been carried out in 45 healthy donors with the Cobe 2997 (Cobe) cell separator, and in 35 with the Fenwal-CS 3000 (CS).


RESULTS
Using this protocol, during the first hour of platelet collection, ionised calcium decreased on average by 18% for CS and by 18.4% for Cobe. During the second hour, Ca2+ and citrate ion concentration did not change with either Cobe or CS (about 65% of citrate ion load is eliminated). We observed mild signs of neuromuscular hyperexcitability in only 22% and 28% of donors with Cobe and CS, respectively. We also found a significant reduction of phosphate ions (p < 0.0001) at the end of the procedures.


CONCLUSIONS
With this stepdown citrate reduction protocol, we obtained a significant reduction of injected citrate without the complication of platelet clumps.
Farrokhi
P
P
Etablissement de Transfusion Sanguine de l'AP-HP, Paris, France.
Farahmand
H
H
Bismuth
A
A
Suarez
C
C
Ducot
B
B
Gillon
M C
MC
Debat
P
P
Laskowski
P
P
Pinon
F
F
D001798:Blood Proteins / Q000032:analysis; D002118:Calcium / Q000097:blood*; D019343:Citric Acid / Q000097:blood*; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007958:Leukocyte Count; D008297:Male; D010292:Paresthesia / Q000139:chemically induced; D010710:Phosphates / Q000032:analysis; D010974:Platelet Aggregation; D010976:Platelet Count; D010983:Plateletpheresis / Q000379:methods*; D013997:Time Factors
D001798:Blood Proteins; D010710:Phosphates; D019343:Citric Acid; D002118:Calcium